II-VI Stock Falls After Q4 Results, Notes Gross Margin Pressure
Benzinga2021-08-10
- II-VI Inc (NASDAQ:IIVI) reported fourth-quarter FY21 revenue growth of 8.3% year-on-year to $808 million, beating the analyst consensus of $783.33 million.
- Segments: Photonic Solutions revenue increased 6.3% Y/Y to $549.7 million. Revenue from Compound Semiconductors rose 12.8% Y/Y to $258.3 million.
- Margins: The non-GAAP gross margin contracted 370 bps to 38.6% as the costs rose 12.7% Y/Y.
- The non-GAAP operating margin expanded 170 bps to 18.4% as the expenses declined 18% Y/Y.
- Non-GAAP operating margin for Compound Semiconductors expanded 810 bps to 23.7%, while contracted 130 bps to 15.9% for Photonic Solutions segment.
- Non-GAAP EPS of $0.88 beat the analyst consensus of $0.76.
- II-VI held $1.6 billion in cash and equivalents as of June 30, 2021, and generated $574.4 million in operating cash flow during FY21.
- The Q4 revenue exceeded the top end of II-VI's guidance with a book-to-bill ratio of 1.14.
- In communications, FY21 revenue improved 11%, driven by 100, 200, 400G datacom transceivers and coherent optics.
- II-VI's life sciences revenue grew by 65% Y/Y in support of COVID and other diagnostic testing.
- II-VI expects the pending acquisition of Coherent Inc (NASDAQ:COHR) to close during the first calendar quarter of 2022.
- Outlook: II-VI sees Q1 FY22 revenue of $780 million - $830 million compared to the analyst consensus of $804.04 million.
- It forecasts a non-GAAP EPS of $0.75 - $0.90 versus the analyst consensus of $0.90.
- Price action: IIVI shares traded lower by 5.30% at $64.26 on the last check Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.